Literature DB >> 17324390

Generation of HSP60-specific regulatory T cell and effect on atherosclerosis.

Keping Yang1, Dazhu Li, Minghua Luo, Yingfeng Hu.   

Abstract

Although CD4(+)CD25(+) regulatory T cells are pivotal in the suppression of autoimmunity, little is known about the effect of antigen-specific regulatory T cells on the formation of atheromatous plaques. Here, we describe the induction of heat-shock protein 60 (HSP60)-specific CD4(+)CD25(high) T cells by rapamycin (RPM)-treated immature dendritic cells in vitro and explore their effect on plaques in apolipoprotein E-deficient mice. Rapamycin-treated bone marrow-derived dendritic cells (DC) were immature, expressing a low level of co-stimulation factors CD86 and CD80. Naive CD4(+) T cells expressed high levels of CD25 and forkhead box P3 (Foxp3) after incubation with rapamycin-treated and HSP60-loaded DC and displayed moderate antigen-specific, IL-10-independent inhibitory function in vitro. After adoptive transfer, HSP60-specific CD4(+)CD25(high) T cells inhibited the formation of plaques, while ovalbumin-specific cells did not. These findings suggest that RPM-treated DC can induce antigen-specific CD4(+)CD25(high) Treg cells that have inhibitory activity in vitro and prevent the development of plaques in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324390     DOI: 10.1016/j.cellimm.2007.01.002

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  13 in total

1.  The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation.

Authors:  Jing Lin; Ming Li; Zhixiao Wang; Shaolin He; Xuming Ma; Dazhu Li
Journal:  J Lipid Res       Date:  2009-12-10       Impact factor: 5.922

Review 2.  Immunomodulation of vascular diseases: atherosclerosis and autoimmunity.

Authors:  G-P Shi
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-02-25       Impact factor: 7.069

Review 3.  Regulatory T cells as a new therapeutic target for atherosclerosis.

Authors:  Han-Xiao Ou; Bing-Bing Guo; Qi Liu; Yu-Kun Li; Zhen Yang; Wen-Jie Feng; Zhong-Cheng Mo
Journal:  Acta Pharmacol Sin       Date:  2018-01-11       Impact factor: 6.150

4.  Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.

Authors:  Elena Maganto-García; Margarite L Tarrio; Nir Grabie; De-xiu Bu; Andrew H Lichtman
Journal:  Circulation       Date:  2011-06-20       Impact factor: 29.690

Review 5.  Treating atherosclerosis with regulatory T cells.

Authors:  Amanda C Foks; Andrew H Lichtman; Johan Kuiper
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-20       Impact factor: 8.311

6.  Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

Authors:  Manikandan Subramanian; Edward Thorp; Goran K Hansson; Ira Tabas
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

7.  Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.

Authors:  Y Zhong; H Tang; X Wang; Q Zeng; Y Liu; X I Zhao; K Yu; H Shi; R Zhu; X Mao
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

8.  CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide.

Authors:  Kuang-Yuh Chyu; Xiaoning Zhao; Paul C Dimayuga; Jianchang Zhou; Xiaojun Li; Juliana Yano; Wai Man Lio; Lai Fan Chan; Jonathan Kirzner; Portia Trinidad; Bojan Cercek; Prediman K Shah
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

Review 9.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

10.  Comprehensive insight into immune regulatory mechanisms and vascular wall determinants of atherogenesis - emerging perspectives of immunomodulation.

Authors:  Maciej Chalubinski; Katarzyna Wojdan; Roksana Dorantowicz; Paulina Jackowska; Paulina Gorzelak; Marlena Broncel
Journal:  Arch Med Sci       Date:  2013-02-21       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.